Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INKT	MINK THERAPEUTICS INC	$59.84M	N/A	-227.20%	105.57%	291.80%	-1.10	0.15	N/A	N/A	N/A
NNOX	NANO-X IMAGING LTD	$189.78M	-32.10%	-28.70%	-33.83%	-74.60%	0.13	4.19	-100.90%	-468.30%	-485.39%
STXS	STEREOTAXIS INC	$207.18M	-597.20%	-55.60%	-93.69%	-298.10%	5.44	1.31	53.10%	-82.80%	-78.56%
CVKD	CADRENAL THERAPEUTICS INC	$24.10M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
NUVL	NUVALENT INC	$7.02B	-39.50%	-35.70%	-42.75%	-44.00%	0.16	10.73	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$193.99M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
RYTM	RHYTHM PHARMACEUTICALS INC	$6.63B	-445.30%	-47.70%	-42.34%	-84.70%	1.42	4.75	89.40%	-113.40%	-97.79%
ATON	ALPHATON CAPITAL CORP	$5.47M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
GCTK	GLUCOTRACK INC	$4.66M	N/A	-402.90%	-368.10%	1,766.70%	0.48	3.27	N/A	N/A	N/A
NCEL	NEWCELX LTD	$1.45M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
CLRB	CELLECTAR BIOSCIENCES INC	$9.26M	-265.50%	-125.70%	-370.52%	391.30%	1.02	2.15	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$8.12B	N/A	-56.50%	-54.98%	-36.10%	-3.76	6.88	100.00%	-862.20%	-816.07%
HYPD	HYPERION DEFI INC	$40.57M	-123.80%	-71.30%	-30.02%	-78.70%	0.17	2.25	-798.10%	-7,643.90%	-6,846.13%
AARD	AARDVARK THERAPEUTICS INC	$215.99M	-54.90%	-37.90%	-39.82%	-58.70%	0.09	12.04	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$102.12M	-50.00%	-40.20%	-49.88%	1,705.00%	0.75	11.98	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$301.32M	-77.90%	-65.80%	-104.98%	-103.60%	0.23	5.16	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.40B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
RMTI	ROCKWELL MEDICAL INC	$36.21M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
LUCD	LUCID DIAGNOSTICS INC	$147.32M	-781.30%	-169.50%	-197.32%	-1,081.40%	1.06	1.90	-58.10%	-1,496.80%	-1,210.75%
IMUX	IMMUNIC INC	$93.70M	-716.20%	-252.10%	-969.85%	507.30%	2.88	1.31	N/A	N/A	N/A
GNPX	GENPREX INC	$2.97M	-822.20%	-393.20%	-1,242.53%	-10,819.70%	1.75	0.84	N/A	N/A	N/A
QLGN	QUALIGEN THERAPEUTICS INC	$14.09M	-90.50%	-65.20%	-19.08%	-420.70%	0.13	8.83	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$858.67M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
REVB	REVELATION BIOSCIENCES INC	$5.33M	-251.20%	-195.30%	-73.88%	573.50%	0.17	6.92	N/A	N/A	N/A
VERU	VERU INC	$37.21M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
OKUR	ONKURE THERAPEUTICS INC	$42.41M	-95.80%	-86.90%	-121.50%	1,899.00%	0.10	11.45	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$79.77M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
CADL	CANDEL THERAPEUTICS INC	$254.73M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$334.42M	-26.40%	-22.10%	-26.87%	-25.40%	0.21	14.08	100.00%	-168.20%	-169.85%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$980.51M	-55.20%	-43.10%	-51.12%	-96.30%	0.29	3.41	24.00%	-158.80%	-159.06%
INO	INOVIO PHARMACEUTICALS INC	$109.82M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
TAOX	TAO SYNERGIES INC	$23.02M	-283.90%	-154.10%	-150.95%	-1,705.40%	0.11	20.51	100.00%	-735,871.70%	-717,300.61%
NMRA	NEUMORA THERAPEUTICS INC	$442.79M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
SY	SO-YOUNG INTERNATIONAL INC	$364.51M	-33.70%	-23.20%	-32.19%	-61.80%	0.45	2.55	55.50%	-46.30%	-46.00%
PHVS	PHARVARIS NV	$1.53B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$35.65M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
ISPC	ISPECIMEN INC	$3.47M	-395.20%	-121.70%	-1,161.87%	323.10%	8.70	0.23	32.60%	-172.50%	-169.69%
GBIO	GENERATION BIO CO	$36.52M	-94.80%	-34.10%	-62.10%	-34.60%	1.41	4.44	100.00%	-410.10%	-410.13%
DNTH	DIANTHUS THERAPEUTICS INC	$1.75B	-33.00%	-31.10%	-22.82%	-34.90%	0.06	17.35	100.00%	-4,104.80%	-4,104.78%
ZURA	ZURA BIO LTD	$265.30M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
COCH	ENVOY MEDICAL INC	$19.23M	N/A	-286.10%	2,455.27%	-128.40%	-2.05	0.64	-294.20%	-13,755.30%	-9,525.96%
OSRH	OSR HOLDINGS INC	$13.22M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
XAIR	BEYOND AIR INC	$11.05M	-272.40%	-119.10%	-129.34%	-123.30%	1.40	4.24	-6.70%	-632.50%	-592.57%
KALA	KALA BIO INC	$4.56M	-369.30%	-65.00%	-119.60%	-154.90%	7.45	1.99	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$274.00M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
NAKA	KINDLY MD INC	$4.67M	-132.20%	-106.90%	-57.87%	-372.90%	0.10	12.99	98.70%	-244.10%	-242.85%
ABSI	ABSCI CORP	$424.05M	-60.20%	-50.90%	-52.98%	-103.30%	0.17	5.89	100.00%	-4,071.20%	-4,051.97%
CRDL	CARDIOL THERAPEUTICS INC	$84.33M	-232.70%	-158.50%	-315.14%	673.60%	0.69	2.47	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-253.40%	-147.00%	-61.57%	750.70%	0.25	4.76	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$1.03B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$3.72M	-476.10%	-253.90%	-674.65%	-20,966.60%	1.54	1.66	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$809.68M	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
CVRX	CVRX INC	$242.97M	-84.50%	-42.10%	-46.13%	-69.50%	1.32	9.62	84.50%	-92.90%	-82.50%
GLSI	GREENWICH LIFESCIENCES INC	$113.40M	-700.90%	-455.70%	-1,249.93%	1,302.30%	1.17	1.85	N/A	N/A	N/A
CDT	CONDUIT PHARMACEUTICALS INC	$3.63M	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$608.32M	-163.50%	-61.20%	-56.38%	-72.20%	1.38	6.61	100.00%	-3,301.60%	-3,301.64%
MGTX	MEIRAGTX HOLDINGS PLC	$659.22M	-1,065.50%	-76.50%	-427.19%	-93.50%	-5.67	0.22	41.00%	-615.30%	-569.48%
BCAB	BIOATLA INC	$46.45M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$2.23B	-26.10%	-24.70%	-27.14%	-31.10%	0.08	14.15	N/A	N/A	N/A
ELUT	ELUTIA INC	$31.86M	N/A	-76.40%	197.10%	-150.20%	-1.67	0.45	46.00%	-125.60%	-111.50%
DMAC	DIAMEDICA THERAPEUTICS INC	$308.82M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$13.10B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$6.45M	N/A	-77.00%	-506.13%	-115.00%	-557.25	0.11	100.00%	-12,940.00%	-6,270.17%
PMVP	PMV PHARMACEUTICALS INC	$73.43M	-55.30%	-51.00%	-69.86%	-78.60%	0.11	10.77	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$141.36M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$231.26M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
NAOV	NANOVIBRONIX INC	$3.52M	-27.60%	-20.90%	-10.47%	4,110.90%	0.27	1.05	32.10%	-231.90%	-201.24%
TENX	TENAX THERAPEUTICS INC	$44.33M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$90.50M	-310.10%	-145.40%	-241.56%	-1,835.00%	2.53	3.18	N/A	N/A	N/A
VIR	VIR BIOTECHNOLOGY INC	$783.27M	-50.80%	-40.60%	-52.89%	-55.50%	0.28	7.25	95.90%	-2,963.50%	-2,961.95%
DCGO	DOCGO INC	$104.66M	-17.20%	-12.50%	-25.25%	-36.70%	0.34	2.59	31.20%	-14.00%	-19.22%
BHVN	BIOHAVEN LTD	$878.60M	-389.90%	-153.40%	-263.08%	-206.40%	-24.84	2.86	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$233.73M	-58.40%	-29.30%	-44.87%	-9,969.30%	1.18	3.36	100.00%	-264.80%	-254.60%
EYPT	EYEPOINT PHARMACEUTICALS INC	$958.68M	-76.10%	-61.70%	-92.76%	-87.80%	0.26	7.18	94.10%	-486.00%	-485.49%
MAIA	MAIA BIOTECHNOLOGY INC	$38.51M	-715.10%	-199.20%	-1,249.70%	434.20%	281.75	1.18	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$47.01M	-261.90%	-150.80%	-249.87%	1,140.10%	3.97	2.59	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$239.38M	-64.40%	-38.70%	-51.82%	-44.80%	0.72	5.76	100.00%	-395.50%	-395.08%
CDXS	CODEXIS INC	$148.58M	-121.40%	-47.40%	-53.78%	-37.00%	2.22	4.12	79.30%	-120.80%	-107.17%
LAB	STANDARD BIOTOOLS INC	$476.86M	-29.30%	-22.40%	-29.33%	-42.40%	0.35	4.38	47.90%	-99.60%	-98.29%
RCKT	ROCKET PHARMACEUTICALS INC	$330.08M	-62.40%	-53.90%	-70.95%	-83.00%	0.17	7.30	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$16.65M	-62.80%	-33.70%	-51.63%	-60.40%	0.92	0.48	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$129.55M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$63.36M	-596.40%	-105.00%	-248.34%	-118.80%	-4.41	1.22	58.80%	-586,864.70%	-586,864.71%
IMA	IMAGENEBIO INC	$91.30M	-36.90%	-33.00%	-30.17%	-58.90%	0.15	13.24	N/A	N/A	N/A
TIL	INSTIL BIO INC	$97.35M	-54.30%	-33.70%	-35.38%	-24.40%	0.75	14.97	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$194.31M	-57.10%	-50.90%	-73.02%	-67.30%	0.19	6.31	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$44.56M	-144.40%	-71.70%	-109.10%	-184.00%	1.69	3.87	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$222.37M	-107.10%	-82.90%	-108.54%	-298.40%	0.36	3.60	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$576.74M	-41.50%	-37.60%	-48.25%	-50.60%	0.15	8.03	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$93.54M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
CLDI	CALIDI BIOTHERAPEUTICS INC	$3.97M	N/A	-203.90%	-198.58%	-815.00%	1.12	2.12	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$233.16M	-196.70%	-118.30%	-121.91%	-306.00%	0.55	5.14	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$2.56B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$13.42B	-311.20%	-262.40%	-463.89%	-997.70%	0.36	3.80	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$313.08M	-45.70%	-40.20%	-53.09%	402.40%	0.13	8.93	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$13.82M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
PCVX	VAXCYTE INC	$6.37B	-21.10%	-19.70%	-22.12%	-22.30%	0.10	8.83	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$330.34M	-73.60%	-60.00%	-70.12%	-112.70%	0.26	6.74	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$242.45M	-13.10%	-8.80%	-8.72%	-10.20%	0.36	3.42	43.90%	-19.80%	-15.03%
SRRK	SCHOLAR ROCK HOLDING CORP	$3.82B	-122.00%	-86.50%	-100.33%	-144.60%	0.68	6.31	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	623	+2.20%	+5.71%	+6.50%	-48.18%	280.44x	5.12x	-28.91%	-10.34%	-18.67%	+51.40%	Strong Buy
Diagnostics & Research	57	-0.54%	-0.05%	+7.81%	+13.10%	24.30x	4.32x	-0.69%	+6.67%	+14.18%	+6.65%	Strong Buy
Drug Manufacturers - General	20	+0.07%	+7.27%	+13.49%	+21.54%	46.21x	6.69x	+109.31%	+12.14%	+20.15%	+1.52%	Hold
Drug Manufacturers - Specialty & Generic	77	+0.26%	+0.39%	-1.67%	-13.53%	25.64x	2.17x	+10.61%	+3.75%	+7.10%	+39.12%	Strong Buy
Healthcare Plans	10	-1.12%	-1.70%	-11.49%	-30.09%	43.50x	1.99x	+12.29%	+3.80%	+9.27%	+22.65%	Buy
Health Information Services	55	-0.49%	-3.70%	-3.58%	-54.29%	41.06x	4.01x	+7.76%	+4.89%	+7.21%	+35.44%	Strong Buy
Medical Care Facilities	48	-0.85%	-1.86%	+0.24%	-21.33%	14.89x	5.29x	-83.73%	+7.67%	+16.73%	+20.32%	Buy
Medical Devices	138	-0.60%	+2.09%	+2.40%	-33.58%	26.64x	3.95x	+12.09%	+7.33%	+8.47%	+25.75%	Strong Buy
Medical Distribution	11	-0.70%	-0.56%	+11.83%	+39.03%	30.11x	433.03x	-34.73%	+3.63%	+22.01%	+4.72%	Buy
Medical Instruments & Supplies	56	-1.36%	-0.06%	+3.18%	-38.36%	198.50x	3.64x	+10.92%	+8.99%	+11.88%	+19.69%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 39, which is 13 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Pediatrix Medical Group has seen its stock return 56.84% over the past year, overperforming other healthcare stocks by 89 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -7.85% from Pediatrix Medical Group's current stock price of $23.15.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 51.9% over the past year, overperforming other healthcare stocks by 84 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $46.67, an upside of 1.49% from Collegium Pharmaceutical's current stock price of $45.98.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Collegium Pharmaceutical, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top healthcare stock out of 1095 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 27, which is 1 points higher than the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 200.39% over the past year, overperforming other healthcare stocks by 232 percentage points.

Indivior has an average 1 year price target of $32.50, an upside of 6.59% from Indivior's current stock price of $30.49.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.09%, which is 11 percentage points higher than the healthcare sector average of 2.04%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.84%, which is 9 percentage points higher than the healthcare sector average of 2.04%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.99%, which is 7 percentage points higher than the healthcare sector average of 2.04%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.35% in the last day, and up 2.29% over the last week. Leap Therapeutics was the among the top gainers in the healthcare sector, gaining 368.04% yesterday.

Leap Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 3.12% in the past year. It has overperformed other stocks in the healthcare sector by 35 percentage points.

2. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -50.82% in the past year. It has underperformed other stocks in the healthcare sector by -19 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -28.31% in the past year. It has overperformed other stocks in the healthcare sector by 4 percentage points.

Are healthcare stocks a good buy now?

54.66% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 28.56% over the next year.

8.08% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.89% of healthcare stocks are rated B (Buy), 46.72% are rated C (Hold), 24.47% are rated D (Sell), and 9.84% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 84.32x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Collegium Pharmaceutical (NASDAQ:COLL)

3. Indivior (NASDAQ:INDV)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Organon & Co (NYSE:OGN)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.